Kelli P. A. MacDonald

GVHD-ASSOCIATED IMMUNE SUPPRESSION IS THE RESULT OF AN INTRINSIC DEFECT IN MHC CLASS II ANTIGEN PRESENTATION WITHIN DONOR DC: 1504

K.A. Markey1, M. Koyama2, R.D. Kuns3, Y.A. Wilson3, S.D. Olver3, N.C. Raffelt3, G.R. Hill3, K.P.A. MacDonald3 1Bone Marrow Transplantation Laboratory, The Queensland Institute of Medical Research, Herston, Brisbane/Queensland/AUSTRALIA, 2Bone Marrow Transplantation Laboratory, The Queensland Institute of Medical Research, Herston, Brisbane/AUSTRALIA, 3Bone Marrow Transplantation Laboratory, The Queensland Institute of Medical Research, Brisbane/AUSTRALIA

Cytokine expanded myeloid precursors function as regulatory antigen presenting cells and induce tolerance through IL-10 producing regulatory T cells

The initiation of graft vs. host disease (GVHD) after stem cell transplantation is dependent on direct antigen presentation by host antigen presenting cells (APC) while the effect of indirect antigen presentation by donor APC is unknown. We have studied the role of indirect antigen presentation in allogenic responses by adding populations of cytokine-expanded donor APC to haematopoietic grafts that would otherwise induce lethal GVHD. Progenipoietin-1 (a synthetic G-CSF/Flt-3 L molecule) and G-CSF expanded myeloid DC, plasmacytoid DC and a novel granulocyte-monocyte precursor population (GM) that differentiate into class IIpos, CD80/CD86pos, CD40neg APC during GVHD. Whereas addition of plasmacytoid and myeloid donor DC augmented GVHD, GM cells induced transplant tolerance via MHC class II restricted generation of IL-10-secreting regulatory T cells. Thus a population of cytokine expanded granulocyte-monocyte precursors function as regulatory antigen presenting cells, suggesting that G-CSF derivatives may have application in disorders characterised by a loss of self-tolerance.